Searched for
SCOPE OPHTHALMICS
Pharma stocks: Moving from ‘What if’ to ‘Maybe not’. 8 pharma stocks, 3 with upside potential above 22%; others not so high, but…- Lupin ties up with Scope Opthalmics to market eyecare products in Mexico
- What drives the sector is key to long term investments: 5 large cap stocks from different sectors with upside potential up to 19%
- Stock market watch: What to expect from the week ending October 15, 2021“A convincing weekly close and bottom base moving up 17,400 to 17,630 are good signs and they hint that Nifty may go up to 18,300-400 in co...11 Oct, 2021, 06.30 AM IST
- Alembic Pharma raises Rs. 750 crore via QIPThe issue was subscribed at a price of Rs. 932 a share, lower than Thursday’s close at Rs. 1081.55 a share on Bombay Stock Exchange.06 Aug, 2020, 07.38 PM IST
- UK government tables new 'cheaper, quicker and easier' Health Visa in ParliamentThe new visa, welcomed by Indian professional groups, will be launched from August to create a new fast-track visa route designed to attrac...14 Jul, 2020, 10.38 PM IST
- Muted Q2 results cast shadow on D-St; top 10 stocks to bet onThe numbers have not been particularly bad, but the recovery everyone is hoping for might be a couple of quarters away.14 Oct, 2015, 03.32 PM IST
- Sharekhan’s top 12 picks which may give up to 50% return in next 6-12 monthsEquity market has underperformed other EMs in the last few months due to rising concerns over subdued growth in the earnings segment.05 May, 2015, 01.38 PM IST
- Sharekhan’s top 12 stocks which can deliver up to 50% return in next 6-12 monthsThe S&P BSE Sensex lost 4.8% in March, the most since February 2013. Brokerage Sharekhan though believes that most of the issues are tempor...03 Apr, 2015, 02.00 PM IST
- Sharekhan’s top twelve stocks which can offer up to 48% return in next 6-12 monthsSharekhan sees ample opportunities in certain pockets of the market and recommends stock picking on a bottom-up basis.07 Mar, 2015, 05.36 PM IST
- Mid-cap pharma stocks can return 20% in 2014, say analystsElara Capital in a report said that they expect revenues to grow at a robust 20 per cent, driven by continued strong performance by Sun Pha...03 Jan, 2014, 07.50 PM IST
- CCI gives green signal to Strides Arcolab-Mylan dealCCI has approved the acquisition of a Strides Arcolab subsidiary by Mylan, saying the deal will not have an adverse impact on competition i...25 Jun, 2013, 03.12 PM IST
Load More
